Open Access<p>Feasibility Study for the Long-Term Management of Refractory Hyperkeratotic Eczema with Calcipotriol and Betamethasone Dipropionate (Daivobet<sup>®</sup>), Viaminate and Concomitant Conventional Therapies: A Retrospective Study</p>
Author(s) -
Amelia Nabatanzi,
Magesa Mafuru,
Musa Male,
Chunxia Tian,
Lingyun Zhang,
Ting Wu,
Shidi Wu,
Changzheng Huang
Publication year - 2020
Publication title -
clinical, cosmetic and investigational dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 35
ISSN - 1178-7015
DOI - 10.2147/ccid.s276148
Subject(s) - calcipotriol , medicine , betamethasone dipropionate , refractory (planetary science) , concomitant , dermatology , gastroenterology , psoriasis , physics , astrobiology
The available treatments for refractory hyperkeratotic eczema are inadequate with frustrating results. We, therefore, incorporated Calcipotriol and Betamethasone Dipropionate (Daivobet ® ), and Viaminate into the mainstay treatment to improve the clinical symptoms. The study aimed to evaluate the efficacy of Daivobet ® and Viaminate as a potential treatment alternative for refractory hyperkeratotic eczema.